NR4A1 and inflammatory breast carcinoma: Moreover, a recent retrospective study in 292 MBC patients reported that the probability of undetectable CTCs was increased in patients with negative hormone receptors, high tumor grade, triple-negative disease, and inflammatory breast cancer [20].